Latest investment in robotic automation advances PharmaLink’s multiyear growth strategy, delivering faster, more accurate pharmaceutical returns processing and maximizing credit recovery for clients.
LARGO, Fla. – November 2026 – PharmaLink, a leading provider of pharmaceutical reverse distribution and returns management solutions, today announced the successful go-live of its new Tompkins Robotics automation system at its Largo, Florida, operations center. This milestone represents another significant step in the company’s ongoing commitment to innovation, operational excellence, and delivering greater value to its clients throughout the pharmaceutical supply chain.
The implementation follows PharmaLink’s previously announced expansion of its flagship operations facility to approximately 150,000 square feet and is a key component of the company’s multiyear strategic investment plan to expand processing capacity, leverage advanced technologies, and continuously improve the speed and accuracy of pharmaceutical returns processing.
Transforming Returns Processing Through Automation
The new Tompkins Robotics system introduces advanced robotic sortation technology into PharmaLink’s returns processing operations, enabling greater efficiency, precision, and consistency in the handling of returned pharmaceutical products.
By automating key elements of the sorting and material-handling process, PharmaLink expects to achieve several important operational improvements:
- Faster Returns Processing: Increased throughput and reduced manual handling help shorten processing cycle times, allowing clients to receive their eligible manufacturer credits sooner.
- Enhanced Accuracy: Automated sortation and product tracking reduce the potential for manual errors, improving processing accuracy and supporting more complete credit recovery.
- Maximized Credit Recovery: Greater processing precision, combined with PharmaLink’s established returns management expertise, helps ensure clients receive the maximum manufacturer credits for which their returned products are eligible.
- Expanded Processing Capacity: Increased automation enables PharmaLink to efficiently accommodate growing customer volumes while maintaining its commitment to quality and service.
- Greater Operational Scalability: The flexible automation platform positions PharmaLink to support continued growth, evolving customer requirements, and future technological advancements.
“Our investment in Tompkins Robotics represents a major advancement in how we process pharmaceutical returns,” said Ray Bodamer, Vice President of Operations at PharmaLink. “By reducing manual touches and automating critical sorting activities, we are improving both the speed and accuracy of our operations. For our customers, that means faster processing, fewer opportunities for errors, and greater confidence that they are receiving every dollar of manufacturer credit they are entitled to. This is an important milestone for our operations team and reinforces our commitment to continuous improvement.”
Delivering on a Multiyear Vision
The successful implementation of Tompkins Robotics is the latest achievement in PharmaLink’s long-term strategy to build a highly efficient, technology-driven pharmaceutical reverse distribution platform.
Beginning with its initial expansion initiatives in 2019, PharmaLink has consistently invested in infrastructure, automation, technology, and operational capabilities to meet the growing demands of the pharmaceutical industry.
The company’s previous investments included facility expansions, automated storage and retrieval technology, and intelligent sortation systems. The latest robotic automation deployment builds upon that foundation, further strengthening PharmaLink’s ability to deliver scalable, accurate, and timely returns processing services.
“This go-live is another example of PharmaLink executing on the long-term vision we established several years ago,” said Thierry Beckers, Chief Executive Officer of PharmaLink. “Our strategy has always been about more than simply expanding our physical footprint. It is about building the infrastructure, technology, and operational capabilities necessary to deliver a superior experience and measurable financial value to our customers. With the implementation of Tompkins Robotics, we are continuing to translate that vision into reality, strengthening our competitive position and creating a platform for continued growth.”
Investing in the Future of Pharmaceutical Reverse Distribution
As pharmaceutical manufacturers, wholesalers, and pharmacies face increasing pressure to improve efficiency, manage costs, and maximize inventory value, PharmaLink remains focused on developing innovative solutions that address these challenges.
The integration of advanced robotics with PharmaLink’s established processing expertise and technology infrastructure provides a foundation for continued improvements in operational performance, credit recovery, and customer service.
The successful go-live reinforces PharmaLink’s commitment to remaining at the forefront of pharmaceutical reverse distribution by investing in technologies that deliver meaningful, long-term value to its customers.
About PharmaLink
PharmaLink is a leading provider of pharmaceutical reverse distribution, product recall, and returns credit management services. Trusted by pharmaceutical manufacturers, wholesale distributors, and pharmacies across multiple classes of trade, PharmaLink combines deep industry expertise, advanced technology, and a commitment to operational excellence to help clients maximize eligible returns credits, improve inventory performance, and maintain regulatory compliance.
For more information, visit www.pharmalinkinc.com or contact PharmaLink at (800) 257-3527.
